|
KLF6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.271980E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.710550E-01 |
| Normal-vs-Stage2 |
5.571600E-01 |
| Normal-vs-Stage3 |
8.106800E-01 |
| Normal-vs-Stage4 |
2.601000E-01 |
| Stage1-vs-Stage2 |
5.587600E-01 |
| Stage1-vs-Stage3 |
3.554400E-02 |
| Stage1-vs-Stage4 |
3.856500E-03 |
| Stage2-vs-Stage3 |
3.950600E-01 |
| Stage2-vs-Stage4 |
1.321030E-01 |
| Stage3-vs-Stage4 |
2.612800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.327240E-01 |
| Normal-vs-AfricanAmerican |
2.486000E-01 |
| Normal-vs-Asian |
5.053200E-01 |
| Caucasian-vs-AfricanAmerican |
9.250200E-01 |
| Caucasian-vs-Asian |
3.245200E-01 |
| AfricanAmerican-vs-Asian |
2.572000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.522200E-01 |
| Normal-vs-Female |
3.939800E-02 |
| Male-vs-Female |
1.469240E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.498800E-01 |
| Normal-vs-Extreme_Weight |
3.864200E-01 |
| Normal-vs-Obese |
1.473240E-01 |
| Normal-vs-Extreme_Obese |
9.479000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.428200E-01 |
| Normal_Weight-vs-Obese |
1.897010E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.442400E-01 |
| Extreme_Weight-vs-Obese |
5.089600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.918000E-01 |
| Obese-vs-Extreme_Obese |
3.739400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.567900E-02 |
| Normal-vs-Age(41-60Yrs) |
1.030240E-01 |
| Normal-vs-Age(61-80Yrs) |
4.458400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.994000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.927600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.966000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.147360E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.491160E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.406400E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.992400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.040100E-02 |
| Normal-VS-Type2 PRCC |
8.574400E-01 |
| Normal-VS-KIRP CIMP |
4.217400E-01 |
| Normal-VS-Unclassified PRCC |
3.268600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.954030E-02 |
| Type1 PRCC-VS-KIRP CIMP |
7.018400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.577800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
5.222400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
3.239800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.714000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.414400E-01 |
| Normal-vs-N1 |
4.261000E-01 |
| Normal-vs-N2 |
2.686800E-01 |
| N0-vs-N1 |
4.830400E-01 |
| N0-vs-N2 |
1.858360E-01 |
| N1-vs-N2 |
8.536000E-02 |
|
|
